Literature DB >> 3878848

Heterogeneity of immune defects in three children with a chronic active Epstein-Barr virus infection.

W Kuis, J J Roord, B J Zegers, A B Rickinson, J G Kapsenberg, H The, J W Stoop.   

Abstract

Three children, all girls, showed long-lasting clinical and serologic evidence of chronic active Epstein-Barr virus (EBV) infection. Extremely high serum titers of IgG- and IgA-type VCA antibodies and EA antibodies were present, whereas EBNA antibody titers were in the range of those found in seropositive individuals. All three patients repeatedly showed the presence of nonspecific pokeweed mitogen (PWM)-activatable suppressor cells in the peripheral blood. The analysis of EBV-specific cytotoxic T cells showed that one patient exhibited normal cytotoxicity, whereas a second patient demonstrated no EBV-specific cytotoxicity together with unusually high levels of virus-infected B cells in the blood and lymph node. The third patient repeatedly showed refractoriness of the circulating B cells to EBV infection, probably on the basis of some developmental defect. It was concluded that each patient has his or her own peculiar defect in the virus-host balance, indicating that heterogeneity may underlie the syndrome of chronic active EBV infection in humans.

Entities:  

Mesh:

Year:  1985        PMID: 3878848     DOI: 10.1007/bf00915334

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  30 in total

1.  Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis.

Authors:  B F Haynes; R T Schooley; C R Payling-Wright; J E Grouse; R Dolin; A S Fauci
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

Review 2.  The Epstein-Barr virus and EB virus infections in childhood.

Authors:  W A Andiman
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

3.  Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children.

Authors:  A J Provisor; J J Iacuone; R R Chilcote; R G Neiburger; F G Crussi
Journal:  N Engl J Med       Date:  1975-07-10       Impact factor: 91.245

4.  Fatal infectious mononucleosis in a family.

Authors:  R S Bar; C J DeLor; K P Clausen; P Hurtubise; W Henle; J F Hewetson
Journal:  N Engl J Med       Date:  1974-02-14       Impact factor: 91.245

5.  Immunopathology of X-linked lymphoproliferative syndrome.

Authors:  D T Purtilo
Journal:  Immunol Today       Date:  1983-10

6.  Indirect immunofluorescence test for detection of IgM antibodies to cytomegalovirus.

Authors:  A C Hekker; B Brand-Saathof; J Vis; R C Meijers
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

7.  T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A.

Authors:  A B Rickinson; M Rowe; I J Hart; Q Y Yao; L E Henderson; H Rabin; M A Epstein
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

8.  Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.

Authors:  S Harada; K Sakamoto; J K Seeley; T Lindsten; T Bechtold; J Yetz; G Rogers; G Pearson; D T Purtilo
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

9.  Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry.

Authors:  D T Purtilo; K Sakamoto; V Barnabei; J Seeley; T Bechtold; G Rogers; J Yetz; S Harada
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

10.  X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.

Authors:  J L Sullivan; K S Byron; F E Brewster; S M Baker; H D Ochs
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

View more
  5 in total

1.  Chronic fatigue syndrome.

Authors: 
Journal:  CMAJ       Date:  1989-02-15       Impact factor: 8.262

2.  Epstein-Barr virus in a CD8-positive T-cell lymphoma.

Authors:  D J Richel; J M Lepoutre; J G Kapsenberg; E C Ooms; W R Boom; C A Boucher; P M Kluin
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

Review 3.  Severe chronic active Epstein-Barr virus infection syndrome.

Authors:  M Okano; S Matsumoto; T Osato; Y Sakiyama; G M Thiele; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Clinical effects of infusing anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection.

Authors:  Masao Hagihara; Takahide Tsuchiya; Osamu Hyodo; Yoko Ueda; Kei Tazume; Aya Masui; Ayako Kanemura; Fumiaki Yoshiba; Shinji Takashimizu; Shohei Matzusaki; Shunichi Kato; Tomomitsu Hotta
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

5.  Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection.

Authors:  H Kimura; I Tsuge; S Imai; M Yamamoto; K Kuzushima; T Osato; T Morishima
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.